| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Radiation Oncology Journal Search > Browse Articles > Search



Peripheral blood lymphocyte changes after stereotactic ablative body radiotherapy to lung or liver metastases in patients with oligometastatic cancers
Sergey Nikolaevich Novikov, Irina Aleksandrovna Baldueva, Anton Yurievich Zozulya, Natalya Viktorovna Emelyanova, Dmitriy Viktorovich Girdyuk, Andrey Ivanovich Arsenyev, Elena Alexandrovna, Elena Ivanovna Tyuryaeva, E. I. Filip Evgenevich Antipov, Mikhail Markovich Girshovich, Sergey Vasilevich Kanayev
Radiat Oncol J. 2023;41(1):23-31.   Published online 2023 Feb 27     DOI: https://doi.org/10.3857/roj.2022.00521
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material   Web of Science 1  Crossref 2
A comparison between high dose rate brachytherapy and stereotactic body radiotherapy boost after elective pelvic irradiation for high and very high-risk prostate cancer
Sergey Nikolaevich Novikov, Roman Vladimirovich Novikov, Yurii Olegovich Merezhko, Mariya Yurevna Gotovchikova, Nikolai Dmitrievich Ilin, Yulia Sergeevna Melnik, Sergey Vasilevich Kanaev
Radiat Oncol J. 2022;40(3):200-207.   Published online 2022 Sep 30     DOI: https://doi.org/10.3857/roj.2022.00339
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 1  Crossref 1
Bone-only oligometastatic prostate cancer: can SABR improve outcomes? A single-center experience
Ángel L. Sánchez-Iglesias, Virginia Morillo-Macías, Ana Santafé-Jiménez, Carlos Ferrer-Albiach
Radiat Oncol J. 2022;40(3):192-199.   Published online 2022 Sep 27     DOI: https://doi.org/10.3857/roj.2022.00101
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 1  Crossref 1
Clinical Investigations
Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy
Abhinav V. Reddy, Colin S. Hill, Shuchi Sehgal, Lei Zheng, Jin He, Daniel A. Laheru, Ana De Jesus-Acosta, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang
Radiat Oncol J. 2022;40(2):111-119.   Published online 2022 May 20     DOI: https://doi.org/10.3857/roj.2021.01060
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material   Web of Science 6  Crossref 5
PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy
Ick Joon Cho, Jae-Uk Jeong, Taek-Keun Nam, Young-Eun Joo, Sung-Bum Cho, Yong-Hyub Kim, Ju-Young Song, Mee Sun Yoon, Sung-Ja Ahn, Woong-Ki Chung
Radiat Oncol J. 2022;40(1):20-28.   Published online 2022 Mar 25     DOI: https://doi.org/10.3857/roj.2021.00934
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 2  Crossref 3
Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection
Abhinav V. Reddy, Colin S. Hill, Shuchi Sehgal, Ding Ding, Amy Hacker-Prietz, Jin He, Lei Zheng, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang
Radiat Oncol J. 2021;39(4):304-314.   Published online 2021 Dec 17     DOI: https://doi.org/10.3857/roj.2021.00815
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material   Web of Science 7  Crossref 6
Computed tomography-based radiomic model predicts radiological response following stereotactic body radiation therapy in early-stage non-small-cell lung cancer and pulmonary oligo-metastases
Ben Man Fei Cheung, Kin Sang Lau, Victor Ho Fun Lee, To Wai Leung, Feng-Ming Spring Kong, Mai Yee Luk, Kwok Keung Yuen
Radiat Oncol J. 2021;39(4):254-264.   Published online 2021 Oct 26     DOI: https://doi.org/10.3857/roj.2021.00311
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material   Web of Science 2  Crossref 2
Combination of yttrium-90 radioembolization with stereotactic body radiation therapy in the treatment of portal vein tumor thrombosis
Jason Liu, Colton Ladbury, Arya Amini, Scott Glaser, Jonathan Kessler, Aram Lee, Yi-Jen Chen
Radiat Oncol J. 2021;39(2):113-121.   Published online 2021 Jun 18     DOI: https://doi.org/10.3857/roj.2021.00213
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 3  Crossref 2
Prospective evaluation of fiducial marker placement quality and toxicity in liver CyberKnife stereotactic body radiotherapy
Debnarayan Dutta, Kaushik Jagannath Kataki, Shibu George, Sruthi K. Reddy, Ajay Sashidharan, Rajesh Kannan, Ram Madhavan, Haridas Nair, Tushar Tatineni, Raghavendra Holla
Radiat Oncol J. 2020;38(4):253-261.   Published online 2020 Nov 30     DOI: https://doi.org/10.3857/roj.2020.00472
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 3  Crossref 3
Clinical Investigationses
Maximum standardized uptake value at pre-treatment PET in estimating lung cancer progression after stereotactic body radiotherapy
Jisun Park, Yunseon Choi, Ki Jung Ahn, Sung Kwang Park, Heunglae Cho, Ji Young Lee
Radiat Oncol J. 2019;37(1):30-36.   Published online 2019 Mar 31     DOI: https://doi.org/10.3857/roj.2019.00010
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 8  Crossref 8
Is higher dose always the right answer in stereotactic body radiation therapy for small hepatocellular carcinoma?
Kyung Hwa Lee, Jeong Il Yu, Hee Chul Park, Su Yeon Park, Jung Suk Shin, Eun Hyuk Shin, Sungkoo Cho, Sang Hoon Jung, Young Yih Han, Do Hoon Lim
Radiat Oncol J. 2018;36(2):129-138.   Published online 2018 Jun 29     DOI: https://doi.org/10.3857/roj.2017.00598
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    PDFSupplementary Material   Web of Science 15  Crossref 16
Clinical Investigations
Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
Hun Jung Kim, Jeong Hoon Phak, Woo Chul Kim
Radiat Oncol J. 2016;34(4):260-264.   Published online 2016 Jun 17     DOI: https://doi.org/10.3857/roj.2015.01571
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 10  Crossref 8
Physics Contribution
A feasibility study evaluating the relationship between dose and focal liver reaction in stereotactic ablative radiotherapy for liver cancer based on intensity change of Gd-EOB-DTPA-enhanced magnetic resonance images
Sang Hoon Jung, Jeong Il Yu, Hee Chul Park, Do Hoon Lim, Youngyih Han
Radiat Oncol J. 2016;34(1):64-75.   Published online 2016 Mar 30     DOI: https://doi.org/10.3857/roj.2016.34.1.64
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 15  Crossref 14
A case report of a patient with squamous cell carcinoma of the face irradiated using a stereotactic technique
Antonio Pontoriero, Giuseppe Iatì, Stefano Pergolizzi
Radiat Oncol J. 2015;33(3):261-264.   Published online 2015 Sep 30     DOI: https://doi.org/10.3857/roj.2015.33.3.261
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 4  Crossref 5
Clinical Investigations
Clinical outcomes of stereotactic body radiotherapy for spinal metastases from hepatocellular carcinoma
Eonju Lee, Tae Gyu Kim, Hee Chul Park, Jeong Il Yu, Do Hoon Lim, Heerim Nam, Hyebin Lee, Joon Hyeok Lee
Radiat Oncol J. 2015;33(3):217-225.   Published online 2015 Sep 30     DOI: https://doi.org/10.3857/roj.2015.33.3.217
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 21  Crossref 20
Stereotactic radiotherapy for early stage non-small cell lung cancer
Umberto Ricardi, Serena Badellino, Andrea Riccardo Filippi
Radiat Oncol J. 2015;33(2):57-65.   Published online 2015 Jun 30     DOI: https://doi.org/10.3857/roj.2015.33.2.57
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Web of Science 38  Crossref 30
Stereotactic body radiotherapy for solitary spine metastasis
Sunyoung Lee, Mison Chun, MiJo Lee
Radiat Oncol J. 2013;31(4):260-266.   Published online 2013 Dec 31     DOI: https://doi.org/10.3857/roj.2013.31.4.260
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Crossref 6
Physics Contributions
Efficient approach for determining four-dimensional computed tomography-based internal target volume in stereotactic radiotherapy of lung cancer
Seung-Gu Yeo, Eun Seog Kim
Radiat Oncol J. 2013;31(4):247-251.   Published online 2013 Dec 31     DOI: https://doi.org/10.3857/roj.2013.31.4.247
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF       Crossref 19
1 |
E-Submission
Principles of Transparency and Best Practice
Author's Index
KOSRO
Journal Impact Factor 2.3
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
HDX Corporation
Elekta Korea
Editorial Office
Department of Radiation Oncology, Samsung Medical Center,
Proton Therapy Center, B2, 81, Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea
Tel : +82-2-3410-3617
E-mail: rojeditor@gmail.com, roj@kosro.or.kr
Copyright © The Korean Society for Radiation Oncology.                      Developed in M2PI
Close layer
prev next